Chemcrux Enterprises Limited (NSE:CHEMCRUX)
India · Delayed Price · Currency is INR 78.73
-0.43 (-0.54%)
At close: Nov 9, 2026
Chemcrux Enterprises Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 921.79 | 806.46 | 700.1 | 784.65 | 951.52 | 952.71 |
Other Revenue | -8.87 | - | - | -0 | - | - |
| 912.92 | 806.46 | 700.1 | 784.65 | 951.52 | 952.71 | |
Revenue Growth | 31.55% | 15.19% | -10.78% | -17.54% | -0.12% | 78.64% |
Cost of Revenue | 385.69 | 338.43 | 286.12 | 324.54 | 437.64 | 502.04 |
Gross Profit | 527.23 | 468.04 | 413.98 | 460.11 | 513.89 | 450.66 |
Selling, General & Admin | 106.95 | 96.76 | 86.36 | 88.92 | 79.66 | 63.37 |
Other Operating Expenses | 293.81 | 257.23 | 233 | 234.81 | 218.54 | 176.28 |
Operating Expenses | 448.17 | 401.32 | 351.42 | 346.57 | 318.57 | 255.53 |
Operating Income | 79.06 | 66.72 | 62.56 | 113.54 | 195.32 | 195.14 |
Interest Expense | -26.88 | -31.15 | -17.38 | -6.47 | -4.55 | -1.38 |
Interest & Investment Income | 1.07 | 1.07 | 7.05 | 3.92 | 2.88 | 0.92 |
Earnings From Equity Investments | - | - | -0.05 | - | - | - |
Currency Exchange Gain (Loss) | 4.74 | 4.74 | 1.88 | 2.13 | 1.92 | 2.26 |
Other Non Operating Income (Expenses) | 0.3 | 0.3 | 0.57 | -0.55 | -3.05 | 0.05 |
EBT Excluding Unusual Items | 58.3 | 41.68 | 54.63 | 112.56 | 192.51 | 196.98 |
Gain (Loss) on Sale of Investments | 11.14 | 11.14 | 2.38 | 3.44 | 3.8 | 2.11 |
Gain (Loss) on Sale of Assets | - | - | 0.6 | - | 0.17 | 0.39 |
Asset Writedown | - | - | - | -1.68 | - | - |
Pretax Income | 69.44 | 52.82 | 57.61 | 114.32 | 196.48 | 199.48 |
Income Tax Expense | 24.65 | 15.51 | 18.47 | 29.87 | 52.9 | 50.89 |
Net Income | 44.79 | 37.31 | 39.13 | 84.44 | 143.58 | 148.59 |
Net Income to Common | 44.79 | 37.31 | 39.13 | 84.44 | 143.58 | 148.59 |
Net Income Growth | 144.34% | -4.66% | -53.66% | -41.19% | -3.37% | 66.32% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Change | 1.90% | - | -0.00% | - | - | 0.00% |
EPS (Basic) | 3.00 | 2.52 | 2.64 | 5.70 | 9.70 | 10.03 |
EPS (Diluted) | 3.00 | 2.52 | 2.64 | 5.70 | 9.70 | 10.03 |
EPS Growth | 140.26% | -4.57% | -53.68% | -41.21% | -3.33% | 66.26% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 182.27 | 87.07 | -8.03 | -79.46 | 36.51 | 45.57 |
Free Cash Flow Per Share | 12.19 | 5.88 | -0.54 | -5.37 | 2.47 | 3.08 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 2.000 | 2.000 |
Dividend Growth | - | 0% | 0% | -50.00% | 0% | 199.98% |
Gross Margin | 57.75% | 58.04% | 59.13% | 58.64% | 54.01% | 47.30% |
Operating Margin | 8.66% | 8.27% | 8.94% | 14.47% | 20.53% | 20.48% |
Profit Margin | 4.91% | 4.63% | 5.59% | 10.76% | 15.09% | 15.60% |
Free Cash Flow Margin | 19.96% | 10.80% | -1.15% | -10.13% | 3.84% | 4.78% |
EBITDA | 125.4 | 112.97 | 93.36 | 135.14 | 214.41 | 209.66 |
EBITDA Margin | 13.74% | 14.01% | 13.33% | 17.22% | 22.53% | 22.01% |
D&A For EBITDA | 46.33 | 46.25 | 30.8 | 21.61 | 19.1 | 14.53 |
EBIT | 79.06 | 66.72 | 62.56 | 113.54 | 195.32 | 195.14 |
EBIT Margin | 8.66% | 8.27% | 8.94% | 14.47% | 20.53% | 20.48% |
Effective Tax Rate | 35.50% | 29.37% | 32.07% | 26.13% | 26.92% | 25.51% |
Revenue as Reported | 933.17 | 826.71 | 714.97 | 798.01 | 962.05 | 962.69 |
Advertising Expenses | - | 0.45 | 0.72 | 0.63 | 0.53 | 0.2 |